| scholarly article | Q13442814 |
| P50 | author | Deepika Darbari | Q59204619 |
| P2093 | author name string | Robert Sheppard Nickel | |
| Lydia H Pecker | |||
| Adam Greenfest | |||
| Sarah Kappa | |||
| P2860 | cites work | Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia | Q33819687 |
| How I use hydroxyurea to treat young patients with sickle cell anemia | Q33985120 | ||
| Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization | Q34026647 | ||
| Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment | Q34187983 | ||
| Well-child care clinical practice redesign for young children: a systematic review of strategies and tools | Q34649646 | ||
| Respect, trust, and the management of sickle cell disease pain in hospital: comparative analysis of concern-raising behaviors, preliminary model, and agenda for international collaborative research to inform practice | Q35601509 | ||
| Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia | Q35843842 | ||
| A randomized controlled trial studying the effectiveness of group medical appointments on self-efficacy and adherence in sickle cell disease (TEAM study): study protocol | Q36095698 | ||
| Impact of hydroxyurea on clinical events in the BABY HUG trial | Q36425423 | ||
| Prevention of conversion to abnormal transcranial Doppler with hydroxyurea in sickle cell anemia: A Phase III international randomized clinical trial | Q36470602 | ||
| Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea. | Q36573473 | ||
| Hydroxyurea use in Children with Sickle Cell Disease: Do Severely Affected Patients Use It and Does It Impact Hospitalization Outcomes? | Q36711806 | ||
| Parental and other factors associated with hydroxyurea use for pediatric sickle cell disease | Q36763705 | ||
| A Mismatch Between Patient Education Materials About Sickle Cell Disease and the Literacy Level of Their Intended Audience | Q36902173 | ||
| Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea | Q37059877 | ||
| Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network | Q37248550 | ||
| Translating sickle cell guidelines into practice for primary care providers with Project ECHO. | Q37442387 | ||
| Adherence to hydroxyurea therapy in children with sickle cell anemia | Q37512157 | ||
| Shared decision making for hydroxyurea treatment initiation in children with sickle cell anemia | Q37612822 | ||
| A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease | Q37622209 | ||
| Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea | Q38446115 | ||
| Hydroxyurea (hydroxycarbamide) for sickle cell disease. | Q38692796 | ||
| Health literacy and disease-specific knowledge of caregivers for children with sickle cell disease. | Q38757824 | ||
| Hydroxyurea effectiveness in children and adolescents with sickle cell anemia: A large retrospective, population-based cohort | Q39268375 | ||
| Hydroxycarbamide treatment and brain MRI/MRA findings in children with sickle cell anaemia. | Q39412777 | ||
| A Clinically Meaningful Fetal Hemoglobin Threshold for Children with Sickle Cell Anemia During Hydroxyurea Therapy. | Q40038732 | ||
| Drowning in a sea of advice: pediatricians and American Academy of Pediatrics policy statements | Q40282776 | ||
| Therapy preference and decision-making among patients with severe sickle cell anemia and their families | Q40321280 | ||
| Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment | Q40738128 | ||
| Well Baby Group Care: Evaluation of a Promising Intervention for Primary Obesity Prevention in Toddlers. | Q40822700 | ||
| Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease | Q41071037 | ||
| Current attitudes of parents and patients toward hematopoietic stem cell transplantation for sickle cell anemia | Q41159892 | ||
| Development and evaluation of a patient empowerment video to promote hydroxyurea adoption in sickle cell disease. | Q42616343 | ||
| Sickle cell disease: primum non nocere (first do no harm). | Q42938341 | ||
| Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists | Q46521677 | ||
| Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority tria | Q47100582 | ||
| Hydroxyurea therapy in UK children with sickle cell anaemia: A single-centre experience | Q48227925 | ||
| Secondary benefit of maintaining normal transcranial Doppler velocities when using hydroxyurea for prevention of severe sickle cell anemia | Q50220234 | ||
| Adverse effect of hydroxyurea on spermatogenesis in patients with sickle cell anemia after 6 months of treatment | Q50261023 | ||
| Bone marrow transplantation for sickle cell disease. A study of parents' decisions | Q68016851 | ||
| Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions | Q74633633 | ||
| P921 | main subject | hydroxycarbamide | Q212272 |
| P304 | page(s) | 221-228.e16 | |
| P577 | publication date | 2018-06-29 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | Targeted Hydroxyurea Education after an Emergency Department Visit Increases Hydroxyurea Use in Children with Sickle Cell Anemia | |
| P478 | volume | 201 |
| Q99416028 | The State of Sickle Cell Disease Care in the United States: How Can Emergency Medicine Contribute? | cites work | P2860 |
Search more.